Viral Hepatitis

You have free access to this content

Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C†‡§

  1. Neal D. Freedman1,‖,*,
  2. James E. Everhart2,
  3. Karen L. Lindsay3,
  4. Marc G. Ghany4,
  5. Teresa M. Curto5,
  6. Mitchell L. Shiffman6,
  7. William M. Lee7,
  8. Anna S. Lok8,
  9. Adrian M. Di Bisceglie9,
  10. Herbert L. Bonkovsky10,¶,
  11. John C. Hoefs11,
  12. Jules L. Dienstag12,
  13. Chihiro Morishima13,
  14. Christian C. Abnet1,
  15. Rashmi Sinha1,
  16. HALT-C Trial Group††

Article first published online: 13 JUL 2009

DOI: 10.1002/hep.23162

Issue

Hepatology

Hepatology

Volume 50, Issue 5, pages 1360–1369, November 2009

Additional Information

How to Cite

Freedman, N. D., Everhart, J. E., Lindsay, K. L., Ghany, M. G., Curto, T. M., Shiffman, M. L., Lee, W. M., Lok, A. S., Di Bisceglie, A. M., Bonkovsky, H. L., Hoefs, J. C., Dienstag, J. L., Morishima, C., Abnet, C. C., Sinha, R. and HALT-C Trial Group (2009), Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology, 50: 1360–1369. doi: 10.1002/hep.23162

Author Information

  1. 1

    Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD

  2. 2

    Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD

  3. 3

    Division of Gastrointestinal and Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, CA

  4. 4

    Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD

  5. 5

    New England Research Institutes, Watertown, MA

  6. 6

    Hepatology Section, Virginia Commonwealth University Medical Center, Richmond, VA

  7. 7

    Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, TX

  8. 8

    Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, MI

  9. 9

    Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO

  10. 10

    Departments of Medicine and Molecular & Structural Biology and The Liver-Biliary-Pancreatic Center, University of Connecticut Health Center, Farmington, CT

  11. 11

    Division of Gastroenterology, University of California—Irvine, Irvine, CA

  12. 12

    Gastrointestinal Unit (Medical Services), Massachusetts General Hospital and the Department of Medicine, Harvard Medical School, Boston, MA

  13. 13

    Virology Division, Department of Laboratory Medicine, University of Washington, Seattle, WA

  1. Carolinas Medical Center, Charlotte, NC

  1. ‖

    fax: 301-496-6829

  2. ††

    The HALT-C Trial was registered with clinicaltrials.gov (#NCT00006164).

*Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, EPS/320, MSC 7232, Rockville, MD 20852

  1. †

    This is publication #38 from the HALT-C Trial Group.

  2. ‡

    Financial relationships of the authors with Hoffmann-La Roche, Inc., are as follows: K.L.L. is a consultant and receives research support; M.L.S. is a consultant, on the speaker's bureau, and receives research support; W.M.L. receives research support; A.S.L. is a consultant; A.M.D. is a consultant, on the speaker's bureau, and receives research support; H.L.B. receives research support; J.C.H. is on the speaker's bureau. Authors with no financial relationships related to this project are: N.D.F., J.E.E., M.G.G., T.M.C., C.C.A., R.S., J.L.D., and C.M.

  3. §

    The funding organizations had no role in the design and conduct of the study; the collection, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.

Publication History

  1. Issue published online: 29 OCT 2009
  2. Article first published online: 13 JUL 2009
  3. Accepted manuscript online: 13 JUL 2009 12:00AM EST
  4. Manuscript Accepted: 2 JUL 2009
  5. Manuscript Received: 17 MAR 2009

Funded by

  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of Allergy and Infectious Diseases
  • National Cancer Institute
  • National Center for Minority Health and Health Disparities and by General Clinical Research Center
  • National Center for Research Resources
  • National Institutes of Health
  • Intramural Research Program of the National Cancer Institute
  • Hoffmann-La Roche, Inc. through a Cooperative Research and Development Agreement with the National Institutes of Health

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (231K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jeffrey W. Molloy, Christopher J. Calcagno, Christopher D. Williams, Frances J. Jones, Dawn M. Torres, Stephen A. Harrison, Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis, Hepatology, 2012, 55, 2
    Direct Link:
  2. 2
    Neal D. Freedman, Jorge A. Marrero, Can Dietary Fish Intake Prevent Liver Cancer?, Gastroenterology, 2012, 142, 7, 1411

    CrossRef

  3. 3
    Hashem B. El-Serag, Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma, Gastroenterology, 2012, 142, 6, 1264

    CrossRef

  4. 4
    Shiv K. Sarin, Manoj Kumar, Natural history of HCV infection, Hepatology International, 2012,

    CrossRef

  5. 5
    Angelo H. Paredes, Dawn M. Torres, Stephen A. Harrison, Nonalcoholic Fatty Liver Disease, Clinics in Liver Disease, 2012, 16, 2, 397

    CrossRef

  6. 6
    Hans L. Tillmann, John G. McHutchison, Zakim and Boyer's Hepatology, 2012,

    CrossRef

  7. 7
    Charlotte E. Costentin, Françoise Roudot-Thoraval, Elie-Serge Zafrani, Fatiha Medkour, Jean-Michel Pawlotsky, Ariane Mallat, Christophe Hézode, Association of caffeine intake and histological features of chronic hepatitis C, Journal of Hepatology, 2011, 54, 6, 1123

    CrossRef

  8. 8
    Neal D. Freedman, Teresa M. Curto, Karen L. Lindsay, Elizabeth C. Wright, Rashmi Sinha, James E. Everhart, Coffee Consumption Is Associated With Response to Peginterferon and Ribavirin Therapy in Patients With Chronic Hepatitis C, Gastroenterology, 2011, 140, 7, 1961

    CrossRef

  9. 9
    Rakesh Jaiswal, Joseph Kiprotich, Nikolai Kuhnert, Determination of the hydroxycinnamate profile of 12 members of the Asteraceae family, Phytochemistry, 2011, 72, 8, 781

    CrossRef

  10. 10
    Daniel Shouval, Focus, Journal of Hepatology, 2011, 54, 6, 1085

    CrossRef

  11. 11
    Anthony Fardet, Jean-François Martin, Jean-Michel Chardigny, Lipotropic capacity of raw plant-based foods: A new index that reflects their lipotrope density profile, Journal of Food Composition and Analysis, 2011, 24, 7, 895

    CrossRef

  12. 12
    Rakesh Jaiswal, Sagar Deshpande, Nikolai Kuhnert, Profiling the chlorogenic acids of Rudbeckia hirta, Helianthus tuberosus, Carlina acaulis and Symphyotrichum novae-angliae leaves by LC-MSn, Phytochemical Analysis, 2011, 22, 5
    Direct Link:
  13. 13
    Arlinking Ong, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Henry Lik-Yuen Chan, The effect of caffeine and alcohol consumption on liver fibrosis – a study of 1045 Asian hepatitis B patients using transient elastography, Liver International, 2011, 31, 7
    Direct Link:
  14. 14
    Anthony Fardet, Jean-François Martin, Jean-Michel Chardigny, Thermal and refining processes, not fermentation, tend to reduce lipotropic capacity of plant-based foods, Food & Function, 2011, 2, 8, 483

    CrossRef

  15. 15
    Melissa Palmer, Gastrointestinal and Liver Disease Nutrition Desk Reference, 2011,

    CrossRef

  16. 16
    Alexander James Thompson, Keyur Patel, Antifibrotic Therapies: Will We Ever Get There?, Current Gastroenterology Reports, 2010, 12, 1, 23

    CrossRef

  17. 17
    Gail Susan Masterton, Peter C. Hayes, Coffee and the liver, European Journal of Gastroenterology & Hepatology, 2010, 22, 11, 1277

    CrossRef

  18. 18
    Sandra Kalthoff, Ursula Ehmer, Nicole Freiberg, Michael P. Manns, Christian P. Strassburg, Coffee Induces Expression of Glucuronosyltransferases by the Aryl Hydrocarbon Receptor and Nrf2 in Liver and Stomach, Gastroenterology, 2010, 139, 5, 1699

    CrossRef

  19. 19
    Paola Vitaglione, Filomena Morisco, Giovanna Mazzone, Daniela Caterina Amoruso, Maria Teresa Ribecco, Antonietta Romano, Vincenzo Fogliano, Nicola Caporaso, Giuseppe D'Argenio, Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins, Hepatology, 2010, 52, 5
    Direct Link:
  20. 20
    Donna L. White, Peter A. Richardson, Mukhtar Al-Saadi, Stephanie J. Fitzgerald, Linda Green, Chami Amaratunge, Manvir Anand, Hashem B. El-Serag, Dietary History and Physical Activity and Risk of Advanced Liver Disease in Veterans with Chronic Hepatitis C Infection, Digestive Diseases and Sciences, 2010, 56, 6, 1835

    CrossRef

  21. 21
    Yasuhiro Asahina, Kaoru Tsuchiya, Nobuharu Tamaki, Itsuko Hirayama, Tomohiro Tanaka, Mitsuaki Sato, Yutaka Yasui, Takanori Hosokawa, Ken Ueda, Teiji Kuzuya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Namiki Izumi, Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection, Hepatology, 2010, 52, 2
    Direct Link:
  22. 22
    Scott L. Friedman, Evolving challenges in hepatic fibrosis, Nature Reviews Gastroenterology & Hepatology, 2010, 7, 8, 425

    CrossRef

  23. 23
    In brief, Nature Reviews Gastroenterology & Hepatology, 2010, 7, 1, 4

    CrossRef

  24. 24
    Brian J. McMahon, Natural History of Chronic Hepatitis B, Clinics in Liver Disease, 2010, 14, 3, 381

    CrossRef

  25. 25
    Tugrul Purnak, Ersan Ozaslan, Coffee intake and chronic hepatitis C, Hepatology, 2009, 50, 5
    Direct Link:
  26. 26
    Neal D. Freedman, Teresa M. Curto, James E. Everhart, Reply:, Hepatology, 2009, 50, 5
    Direct Link:
  27. 27
    Scott L. Friedman, Hepatic Fibrosis,
    Direct Link:
  28. 28
    Jama M. Darling, Stanley M. Lemon, Michael W. Fried, Hepatitis C,
    Direct Link:
View Full Article (HTML) Get PDF (231K)